Survivor Story
Lourdes Monje was diagnosed with metastatic breast cancer at just 25 years of age and must confront the many unique challenges as a young adult diagnosed with a terminal illness.
Read Lourdes' Story
Lourdes Monje was diagnosed with metastatic breast cancer at just 25 years of age and must confront the many unique challenges as a young adult diagnosed with a terminal illness.
Read Lourdes' Story
Cancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreIn the new episode of Believe in Progress, Mitch talks with Jason Tharp, a brain cancer survivor, resilience expert, author, illustrator, and patient advocate, about his life-changing diagnosis to creating “H.O.P.E. Is a Strategy.”
Learn MoreNearly 235,000 people living in the United States will be diagnosed with lung cancer this year. Learn about prevention, screening, and treatment options for lung cancer.
Learn MoreScreening for Early Detection: Using evidence-based guidelines to screen for cancer can help find aberrations at the earliest possible detectable phase of cancer development and progression.
Read the ReportRead about recent U.S. Food and Drug Administration approvals of products for cancer prevention, diagnosis, and treatment.
Learn MoreYour donation to the American Association for Cancer Research will help fund early-career investigators. Fund the future of cancer research today.
Donate NowRegister now to get the lowest rate for the AACR Annual Meeting 2025 (April 25-30, Chicago).
Deadline: January 3
The AACR Cancer Progress Report 2024 highlights research-driven advances against the collection of often devastating diseases we call cancer.
Learn MoreThe AACR and its more than 58,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreDr. LoRusso, AACR President 2024-2025, explains that basic cancer research is essential to accelerating advances in cancer science and medicine.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2021
Learn Moretherapeutics were approved for new or expanded uses by the FDA from July 1, 2023, to June 30, 2024
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now
